Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary-progressive Multiple Sclerosis (SPMS)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02308137
What this trial is testing

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis, Secondary Progressive
University of Calgary 64
Not applicableEnded earlyNCT02296346
What this trial is testing

Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
University of Utah 13
Not applicableStudy completedNCT04593927
What this trial is testing

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals 451
Not applicableStudy completedNCT03983681
What this trial is testing

Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

Who this might be right for
Multiple Sclerosis
Kessler Foundation 81
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Not applicableEnded earlyNCT04895202
What this trial is testing

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study

Who this might be right for
Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Large-scale testing (Phase 3)Study completedNCT03387670
What this trial is testing

Multiple Sclerosis-Simvastatin Trial 2

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
University College, London 964
Large-scale testing (Phase 3)WithdrawnNCT00313976
What this trial is testing

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis
Bayer
Not applicableStudy completedNCT07168694
What this trial is testing

A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia

Who this might be right for
Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 606